Broadridge Financial Solutions filings document a NYSE-listed financial technology company with common stock registered under the Exchange Act. The company’s Form 8-K disclosures cover operating and financial results, Regulation FD investor presentations, dividend declarations, board composition changes, annual meeting voting results, and other material events.
Broadridge’s regulatory record also includes capital-structure and securities disclosures tied to its public equity and debt activity, along with governance matters such as director elections, executive compensation votes, auditor ratification, committee assignments, and risk-factor language accompanying investor materials and earnings releases.
Broadridge Financial Solutions director reports issuer share disposition
On February 25, 2026, an entity identified as BOMAR II LLC, associated with director Robert N. Duelks, disposed of 486 shares of Broadridge common stock to the issuer at $177.035 per share. After this transaction, BOMAR II LLC held 4,474 shares indirectly. As of the same date, Duelks also reported 20,815 shares held directly and additional indirect holdings of 17,000 shares in the Mary E. Duelks 2007 Revocable Trust and 8,853 shares in the Robert N. Duelks 2007 Revocable Trust.
Robert N. Duelks 2007 Revocable Trust reported a proposed sale of 486 common shares under Rule 144 tied to restricted stock vesting. The filing also shows the trust sold 253 common shares on 02/06/2026.
This is a routine Rule 144 notice of a trustee-held block of common stock being offered for sale; timing and proceeds details are not included in the excerpt.
BROADRIDGE FINANCIAL SOLUTIONS, INC. director Patricia Ann Mosconi filed an amended ownership report showing she held 10 shares of Broadridge common stock as of February 2, 2026. This Form 3/A does not describe a new purchase or sale, but updates her reported holdings.
Broadridge Financial Solutions, Inc. director Patricia Ann Mosconi filed an initial statement of beneficial ownership (Form 3) as of 02/02/2026. The filing reports that she has no securities beneficially owned in the company, and there are no listed non-derivative or derivative holdings.
State Street Corporation has filed a Schedule 13G reporting beneficial ownership of 5,995,200 shares of Broadridge Financial Solutions Inc. common stock, representing 5.1% of the class as of the event date. State Street reports shared voting power over 3,674,915 shares and shared dispositive power over 5,994,841 shares, with no sole voting or dispositive power. The securities are certified as held in the ordinary course of business and not for the purpose of changing or influencing control of Broadridge.
Broadridge Financial Solutions used this update to share its February 2026 investor presentation and highlight recent performance and outlook. For the second quarter of fiscal 2026, Recurring revenues rose to $1,070 million, up 9%, and total revenues reached $1,714 million, up 8% year over year. GAAP diluted EPS more than doubled to $2.42 from $1.20, helped by non‑recurring items, while Adjusted EPS increased more modestly to $1.59 from $1.56. Adjusted Operating income was $265 million with a 15.5% margin, slightly below 16.6% a year earlier. Closed sales were $57 million, up 24%, supporting future Recurring revenue. Broadridge reaffirmed its fiscal 2026 Recurring revenue growth outlook of 5–7% in constant currency and Adjusted Operating income margin of 20–21%, and raised its Adjusted EPS growth guidance to 9–12%, keeping it on track with its three‑year financial objectives.
BR filed a Rule 144 notice for a planned sale of restricted common stock. The filing covers the potential sale of 253 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $48,727.80 on the NYSE.
The shares were acquired on 06/05/2024 through restricted stock vesting under a registered plan with the issuer. As context, 116,748,715 common shares were outstanding. The approximate sale date indicated is 02/06/2026, and the seller represents they are unaware of undisclosed material adverse information about the issuer.
Broadridge Financial Solutions director Robert N. Duelks reported a small sale of company stock. On February 6, 2026, he sold 253 shares of common stock at $192.6 per share, and held 20,815 shares directly afterward.
He also reported indirect ownership of Broadridge common stock, including 4,960 shares through BOMAR II LLC, 17,000 shares through the Mary E. Duelks 2007 Revocable Trust, and 8,853 shares through the Robert N. Duelks 2007 Revocable Trust.
Broadridge Financial Solutions reported strong quarterly growth for the three months ended December 31, 2025. Revenues rose to $1,713.9 million from $1,589.2 million, while net earnings doubled to $284.6 million from $142.4 million. Diluted earnings per share increased to $2.42 from $1.20.
Growth was broad-based: Investor Communication Solutions revenue reached $1,233.3 million and Global Technology and Operations recurring revenues were $480.6 million. Results were also boosted by digital asset activity, with $188.0 million of other non-operating income in the quarter and Canton Coin holdings valued at $214.8 million.
Operating cash flows improved to $367.1 million for the six-month period, supporting dividends of $216.9 million and $152.5 million of share repurchases. Total assets were $8,639.5 million and total debt was $3,185.1 million, with 116.7 million common shares outstanding as of December 31, 2025.
Broadridge Financial Solutions, Inc. furnished an update on its business performance by issuing a press release and posting an earnings webcast presentation covering the second quarter of fiscal 2026, which ended on December 31, 2025. Both documents were released on February 3, 2026 and are available through the company’s investor relations website.
The materials, attached as Exhibits 99.1 and 99.2, are furnished rather than filed, limiting their exposure to certain Exchange Act liabilities. The company also included extensive cautionary language on forward-looking statements, directing investors to its June 30, 2025 Form 10-K risk factors for additional detail.